Intelligent Bio Solutions Inc (INBS)
1.2100 x 5 1.3100 x 3
Post-market by (Cboe BZX)
1.2700 +0.0500 (+4.10%) 04/11/25 [NASDAQ]
1.2100 x 5 1.3100 x 3
Post-market 1.2281 -0.0419 (-3.30%) 19:59 ET
for Fri, Apr 11th, 2025
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -10,191 | -10,665 | -8,334 | -7,060 | -3,193 |
Depreciation Amortization | 974 | 4,973 | N/A | N/A | N/A |
Accounts receivable | -136 | -294 | N/A | N/A | 118 |
Accounts payable and accrued liabilities | -633 | 85 | 243 | -973 | 2,410 |
Other Working Capital | -702 | 79 | 2,439 | -4,941 | 2,627 |
Other Operating Activity | 1,116 | -1,556 | 2,294 | 1,677 | -2,461 |
Operating Cash Flow | $-9,572 | $-7,377 | $-3,358 | $-11,297 | $-499 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | N/A | N/A | -14 |
PPE Investments | -221 | -505 | -380 | N/A | N/A |
Net Acquisitions | N/A | -189 | N/A | N/A | N/A |
Other Investing Activity | 0 | 0 | -500 | 0 | 0 |
Investing Cash Flow | $-221 | $-694 | $-880 | $0 | $-14 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 14,561 | 2,555 | N/A | 22,112 | N/A |
Other Financing Activity | 0 | -1,119 | 0 | 1,291 | 734 |
Financing Cash Flow | $14,561 | $1,435 | $N/A | $23,403 | $734 |
Exchange Rate Effect | -1 | -65 | -97 | 40 | 8 |
Beginning Cash Position | 1,537 | 8,238 | 12,574 | 427 | 198 |
End Cash Position | 6,304 | 1,537 | 8,238 | 12,574 | 427 |
Net Cash Flow | $4,767 | $-6,701 | $-4,335 | $12,146 | $229 |
Free Cash Flow | |||||
Operating Cash Flow | -9,572 | -7,377 | -3,358 | -11,297 | -499 |
Capital Expenditure | -221 | -505 | -380 | N/A | N/A |
Free Cash Flow | -9,793 | -7,883 | -3,738 | -11,297 | -499 |